Your browser doesn't support javascript.
loading
N6-methyladenosine modification regulates imatinib resistance of gastrointestinal stromal tumor by enhancing the expression of multidrug transporter MRP1.
Xu, Kangjing; Zhang, Qiang; Chen, Ming; Li, Bowen; Wang, Nuofan; Li, Chao; Gao, Zhishuang; Zhang, Diancai; Yang, Li; Xu, Zekuan; Li, Xueming; Xu, Hao.
Affiliation
  • Xu K; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, Nanjing, 211166, China.
  • Zhang Q; Department of Gastrointestinal Surgery, The Second People's Hospital of Lianyungang Affiliated to Kangda College, Nanjing Medical University, Lianyungang, 222002, China.
  • Chen M; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, Nanjing, 211166, China.
  • Li B; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, Nanjing, 211166, China.
  • Wang N; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, Nanjing, 211166, China.
  • Li C; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, Nanjing, 211166, China.
  • Gao Z; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, Nanjing, 211166, China.
  • Zhang D; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, Nanjing, 211166, China.
  • Yang L; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, Nanjing, 211166, China.
  • Xu Z; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, Nanjing, 211166, China.
  • Li X; School of Pharmaceutical Science, Nanjing Tech University, Nanjing, 211816, China. Electronic address: Xuemingli@njtech.edu.cn.
  • Xu H; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, Nanjing, 211166, China. Electronic a
Cancer Lett ; 530: 85-99, 2022 04 01.
Article in En | MEDLINE | ID: mdl-35032557
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Adenosine / Drug Resistance, Neoplasm / Multidrug Resistance-Associated Proteins / Gastrointestinal Stromal Tumors / Imatinib Mesylate Limits: Animals / Female / Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Adenosine / Drug Resistance, Neoplasm / Multidrug Resistance-Associated Proteins / Gastrointestinal Stromal Tumors / Imatinib Mesylate Limits: Animals / Female / Humans Language: En Year: 2022 Type: Article